Title : EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.

Pub. Date : 2016 Mar

PMID : 26832794






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib. vandetanib epidermal growth factor receptor Homo sapiens
2 The effect of the TKI vandetanib on proliferation and tumor growth response of MCF-7 cells was dependent upon expression of TFAP2C, and dual KD of RET and EGFR eliminated the effects of vandetanib. vandetanib epidermal growth factor receptor Homo sapiens
3 Response to vandetanib was mediated through the TFAP2C target genes EGFR and RET. vandetanib epidermal growth factor receptor Homo sapiens